Jobst von Einem

Ludwig-Maximilians-Universität München

Papers

1

Total Citations

9

H-Index

1

About

Jobst von Einem is a leading figure in the advancement of stereotactic body radiotherapy (SBRT) for treating metastatic liver disease. His research centers on the clinical application of robotic radiosurgery, particularly using the CyberKnife device, to achieve precise, high-dose tumor ablation while sparing healthy tissue. Von Einem’s most cited work, a 2018 study on long-term survival in patients treated for liver metastases, provides critical evidence that radiosurgery can offer durable local control and survival outcomes comparable to surgical resection. This study, with 9 citations, addresses a key question in oncologic care by demonstrating the efficacy of a non-invasive alternative for patients who are not surgical candidates. Beyond this landmark paper, his contributions have helped define patient selection criteria and treatment protocols that optimize outcomes for those with oligometastatic disease. By bridging the gap between radiation oncology and surgical oncology, von Einem has established a robust framework for integrating robotic radiosurgery into standard clinical practice, offering new hope for patients with limited metastatic spread.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases
9 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Ludwig-Maximilians-Universität München

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago